As of February 2023 Onconova Therapeutics has a market cap of $24.69 Million. This makes Onconova Therapeutics the world's 7001th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $24.69 M | 82.75% |
2022 | $13.51 M | -74.64% |
2021 | $53.27 M | -38.16% |
2020 | $86.14 M | 102.34% |
2019 | $42.57 M | 255.62% |
2018 | $11.97 M | -25.9% |
2017 | $16.15 M | 5.29% |
2016 | $15.34 M | -37.02% |
2015 | $24.36 M | -65.88% |
2014 | $71.4 M | -71.03% |
2013 | $0.24 B |
On Feb 6th, 2023 the market cap of Onconova Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Baxter BAX | $22.76 B | 92,097.79% | ๐บ๐ธ USA |
![]() Spectrum Pharmaceuticals
SPPI | $0.16 B | 574.65% | ๐บ๐ธ USA |
![]() CTI BioPharma
CTIC | $0.70 B | 2,736.69% | ๐บ๐ธ USA |
![]() Cleveland BioLabs
CBLI | $49.06 M | 98.72% | ๐บ๐ธ USA |
![]() Array Technologies ARRY | $3.13 B | 12,576.68% | ๐บ๐ธ USA |